SCHEINBERG, DAVID A.,GARDNER, THOMAS J.,TAN, DEREK S.,LEE, JONGHAN,LORENZ, IVO
申请号:
CA3068639
公开号:
CA3068639A1
申请日:
2018.07.02
申请国别(地区):
CA
年份:
2019
代理人:
摘要:
Provided herein are compositions and methods for adoptive cell therapy comprising engineered immune cells that express an antigen-targeted chimeric antigen receptor and a prodrug converting enzyme for the treatment of inflammation, inflammatory diseases, or pathogenic infections.